SCHEMBL20879262

SCHEMBL20879262

CCCC(O)c1cccc(OC)c1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
TP53 P04637 1/20 0.40
ADRA2B P18089 2/20 0.40
ADRB1 P08588 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRB3 P13945 1/20 0.40
ADRA2C P18825 1/20 0.40
DRD2 P14416 1/20 0.39
DRD1 P21728 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HRH1 P35367 1/20 0.39
ADRA1B P35368 1/20 0.39
OPRK1 P41145 1/20 0.39
HTR2B P41595 1/20 0.39
KCNQ1 P51787 1/20 0.39
KCNH2 Q12809 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14692188 0.87 ADRA2A (0.40) ADRA2BADRB1ADRA2AADRB3ADRA2C
SCHEMBL14691515 0.86 ADRA2A (0.39) TP53ADRA2BADRB1ADRA2AADRB3
SCHEMBL6055320 0.84 PPARG (0.49) TP53POLBHTTNPSR1L3MBTL1
SCHEMBL30669716 0.84 PPARG (0.49) TP53POLBHTTNPSR1L3MBTL1
Ammonia Solution, Strong SCHEMBL28835220 0.83 PPARG (0.48) TP53POLBHTTNPSR1L3MBTL1
SCHEMBL13570094 0.82 ALDH1A1 (0.50) TAS1R3TAS1R1ADRA2BDRD2DRD1
SCHEMBL13263813 0.81 TAS1R3 (0.40) TAS1R3TAS1R1TP53ADRA2BADRA2A
SCHEMBL6742344 0.81 TAS1R3 (0.40) TAS1R3TAS1R1TP53ADRA2APPARG
SCHEMBL6745045 0.81 TAS1R3 (0.40) TAS1R3TAS1R1TP53ADRA2APPARG
SCHEMBL10091381 0.80 CES2 (0.45) TAS1R3TAS1R1ADRA2BADRB1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3070087-B1 INTERMEDIATES FOR THE SYNTHESIS OF CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2019-04-10 EP disclosed